Hong et al. reported that a poor response rate to PD-1 blockade may be attributed to the co-expression of other checkpoint receptors in the immunosuppressive tumor microenvironment, including VISTA (Hong et al. 2019). The gene discussed is VSIR; the disease is neoplasm.